217 related articles for article (PubMed ID: 25620059)
1. Genistein modulates the expression of NF-κB and MAPK (p-38 and ERK1/2), thereby attenuating d-Galactosamine induced fulminant hepatic failure in Wistar rats.
Ganai AA; Khan AA; Malik ZA; Farooqi H
Toxicol Appl Pharmacol; 2015 Mar; 283(2):139-46. PubMed ID: 25620059
[TBL] [Abstract][Full Text] [Related]
2. Hepatoprotective effect of cryptotanshinone from Salvia miltiorrhiza in D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
Jin Q; Jiang S; Wu YL; Bai T; Yang Y; Jin X; Lian LH; Nan JX
Phytomedicine; 2014 Jan; 21(2):141-7. PubMed ID: 24011530
[TBL] [Abstract][Full Text] [Related]
3. Role of α-lipoic acid in LPS/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis.
Xia X; Su C; Fu J; Zhang P; Jiang X; Xu D; Hu L; Song E; Song Y
Int Immunopharmacol; 2014 Oct; 22(2):293-302. PubMed ID: 25046589
[TBL] [Abstract][Full Text] [Related]
4. Genistein attenuates D-GalN induced liver fibrosis/chronic liver damage in rats by blocking the TGF-β/Smad signaling pathways.
Ganai AA; Husain M
Chem Biol Interact; 2017 Jan; 261():80-85. PubMed ID: 27876602
[TBL] [Abstract][Full Text] [Related]
5. Scoparone attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure through inhibition of toll-like receptor 4 signaling in mice.
Kang JW; Kim DW; Choi JS; Kim YS; Lee SM
Food Chem Toxicol; 2013 Jul; 57():132-9. PubMed ID: 23535186
[TBL] [Abstract][Full Text] [Related]
6. Baicalein inhibits nuclear factor-κB and apoptosis via c-FLIP and MAPK in D-GalN/LPS induced acute liver failure in murine models.
Wu YL; Lian LH; Wan Y; Nan JX
Chem Biol Interact; 2010 Dec; 188(3):526-34. PubMed ID: 20850421
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of sea buckthorn polysaccharide extracts against LPS/d-GalN-induced acute liver failure in mice via suppressing TLR4-NF-κB signaling.
Liu H; Zhang W; Dong S; Song L; Zhao S; Wu C; Wang X; Liu F; Xie J; Wang J; Wang Y
J Ethnopharmacol; 2015 Dec; 176():69-78. PubMed ID: 26494508
[TBL] [Abstract][Full Text] [Related]
8. CQMUH-011, a novel adamantane sulfonamide compound, inhibits lipopolysaccharide- and D-galactosamine-induced fulminant hepatic failure in mice.
Yan L; Hu X; Wu Q; Jiang R; Zhang S; Ling Q; Liu H; Jiang X; Wan J; Liu Y
Int Immunopharmacol; 2017 Jun; 47():231-243. PubMed ID: 28433945
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of neutrophil elastase inhibitor (FR136706) in lethal acute liver failure induced by D-galactosamine and lipopolysaccharide in rats.
Uchida Y; Kaibori M; Hijikawa T; Ishizaki M; Ozaki T; Tanaka H; Matsui K; Tokuhara K; Kwon AH; Kamiyama Y; Okumura T
J Surg Res; 2008 Mar; 145(1):57-65. PubMed ID: 17936791
[TBL] [Abstract][Full Text] [Related]
10. Synthetic RGDS peptide attenuated lipopolysaccharide/D-galactosamine-induced fulminant hepatic failure in mice.
Yin X; Gong X; Jiang R; Zhang L; Wang B; Xu G; Wang C; Wan J
J Gastroenterol Hepatol; 2014 Jun; 29(6):1308-15. PubMed ID: 24476051
[TBL] [Abstract][Full Text] [Related]
11. Magnesium isoglycyrrhizinate attenuates D-galactosamine/lipopolysaccharides induced acute liver injury of rat via regulation of the p38-MAPK and NF-κB signaling pathways.
Wang W; Li X; Xu J
Immunopharmacol Immunotoxicol; 2018 Jun; 40(3):262-267. PubMed ID: 29486613
[TBL] [Abstract][Full Text] [Related]
12. Madecassoside prevents acute liver failure in LPS/D-GalN-induced mice by inhibiting p38/NF-κB and activating Nrf2/HO-1 signaling.
Wang W; Wu L; Li Q; Zhang Z; Xu L; Lin C; Gao L; Zhao K; Liang F; Zhang Q; Zhou M; Jiang W
Biomed Pharmacother; 2018 Jul; 103():1137-1145. PubMed ID: 29715757
[TBL] [Abstract][Full Text] [Related]
13. Glycine propionyl l-carnitine attenuates d-Galactosamine induced fulminant hepatic failure in wistar rats.
Ganai AA; Jahan S; Ahad A; Abdin MZ; Farooqi H
Chem Biol Interact; 2014 May; 214():33-40. PubMed ID: 24565947
[TBL] [Abstract][Full Text] [Related]
14. Glycyrrhetinic acid attenuates lipopolysaccharide-induced fulminant hepatic failure in d-galactosamine-sensitized mice by up-regulating expression of interleukin-1 receptor-associated kinase-M.
Yin X; Gong X; Zhang L; Jiang R; Kuang G; Wang B; Chen X; Wan J
Toxicol Appl Pharmacol; 2017 Apr; 320():8-16. PubMed ID: 28213090
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of Mg-CUD against D-galactosamine-induced hepatotoxicity in rats.
Choi JH; Kang JW; Kim DW; Sung YK; Lee SM
Eur J Pharmacol; 2011 Apr; 657(1-3):138-43. PubMed ID: 21284943
[TBL] [Abstract][Full Text] [Related]
16. Protective mechanisms of acacetin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure in mice.
Cho HI; Park JH; Choi HS; Kwak JH; Lee DU; Lee SK; Lee SM
J Nat Prod; 2014 Nov; 77(11):2497-503. PubMed ID: 25382719
[TBL] [Abstract][Full Text] [Related]
17. [Protective effect of glycogen synthase kinase 3β inhibition via peroxisome proliferator-activated receptor alpha activation in mice with acute liver failure].
Shi HB; Shi HL; Zhang XY; Chen DX; Duan ZP; Ren F
Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):211-216. PubMed ID: 28482409
[No Abstract] [Full Text] [Related]
18. Pseudoephedrine/ephedrine shows potent anti-inflammatory activity against TNF-α-mediated acute liver failure induced by lipopolysaccharide/D-galactosamine.
Wu Z; Kong X; Zhang T; Ye J; Fang Z; Yang X
Eur J Pharmacol; 2014 Feb; 724():112-21. PubMed ID: 24365491
[TBL] [Abstract][Full Text] [Related]
19. Atractylodin ameliorates lipopolysaccharide and d-galactosamine-induced acute liver failure via the suppression of inflammation and oxidative stress.
Lyu Z; Ji X; Chen G; An B
Int Immunopharmacol; 2019 Jul; 72():348-357. PubMed ID: 31030090
[TBL] [Abstract][Full Text] [Related]
20. Cordyceps sinensis prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
Cheng YJ; Cheng SM; Teng YH; Shyu WC; Chen HL; Lee SD
Am J Chin Med; 2014; 42(2):427-41. PubMed ID: 24707872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
